Skip to content
Menu

Head-to-head comparison

CoreAge Rx vs Lttl

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #1Desk pick
CoreAge Rx

One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · Verified August 2026

Marked down on: The advertised $99/$149 per month is a 12-month plan paid in full ($1,188 / $1,788 up front); no month-to-month price is published

vs
Ranked #202
Lttl

Lttl (pronounced “little”) publishes its entire term ladder on one public page — every medication, route and commitment length, month-to-month rung included — alongside compounded semaglutide and tirzepatide, a low-dose microdose line and a longevity range.

$199/mo sema · $279/mo tirz · Verified August 2026

Marked down on: One advertised figure is purchasable at no tier: every product card prints the same “from $129/mo”, including tirzepatide, whose own four rungs are $279, $249, $229 and $199

CoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

CoreAge Rx

94/100

A

Overall

Lttl

66/100

C

Price transparency

96
78

State access

98
24

Molecule range

90
90

Onboarding speed

92
70

Support responsiveness

93
73

Licensing & trust

94
65

The spec sheet

FieldCoreAge RxLttl
Semaglutide$99/mo12-month prepay$99/mo only as a 12-month plan paid in full ($1,188 in one charge); the lander says "starting at, based on a 12-month plan paid in full"; no month-to-month price is published; same price at every dose; compounded injectable$199/mo$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay)
Tirzepatide$149/mo12-month prepay$149/mo only as a 12-month plan paid in full ($1,788 in one charge); no month-to-month price is published; same price at every dose; compounded injectable$279/mo$279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay)
CoverageAll 50 statesNot listed on Lttl's site (checked August 2026)
Brand-nameCompounded onlyYes
Oral optionInjectable onlyYes
Best forAnyone who can prepay a year and wants one dose-independent price with full nationwide reach.Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.
Desk Score94/100A66/100C

The verdict

Desk pick — CoreAge Rx

CoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Choose CoreAge Rx if…

Anyone who can prepay a year and wants one dose-independent price with full nationwide reach.

$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · All 50 states

Choose Lttl if…

Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.

$199/mo sema · $279/mo tirz

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: CoreAge Rx · Lttl.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.